Reaching new heights in biomarker solutions Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications
In Safe Hands Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications
Setting New Standards Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications
Ahead of the Pack Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications
Leading from the Front Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications

Biomarker Assays

Biomarker Assays
Rapid development of TMT-SRM mass spectrometry assays for biomarker validation and routine measurement Learn More

Biomarker Services

Biomarker Services
Unique peptidomic and proteomic workflows using TMT with LTQ Orbitrap for maximum coverage in discovery and validation Learn More

Proprietary Biomarkers

Proprietary Biomarkers
Biomarkers for Alzheimer's disease, stroke, cancer and other indications Learn More

What's new

New Product Announcement: Introducing Tau Phosphoprotein Assays for Tauopathies & Alzheimer's Disease

Learn More

News

1 of 3
25 Apr, 2012 / 'Alzheimer's disease treatments and tests on the horizon’ by Professor Simon Lovestone. The Royal Society of Chemistry Public Lecture on Alzheimer's Disease Treatments and Tests
Read More
24 Apr, 2012 / PS Highlighted in a Patexia Editorial- "Are we funding the right cancer research?" By understanding what precisely is going on at the protein level, we can understand how cancer actually functions.
Read More

Events

20 May, 2012 / American Society For Mass Spectrometry The American Society for Mass Spectrometry (ASMS) was formed in 1969 to promote and disseminate knowledge of…

Read More
01 Jun, 2012 / ASCO Annual Meeting 2012 The ASCO Annual Meeting brings together more than 25,000 oncology professionals from a broad range of…

Read More